ACADIAN ASSET MANAGEMENT LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 916542
Boston, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,923,261
+$9,372,165 QoQ
Shares Held
42,122
+62.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#251
of 1,705 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $730,930,536 across 167 Biotechnology names. VRTX ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,923,261 | 42,122 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $11,551,096 | 25,868 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,069,125 | 22,210 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $100,651 | 257 | Shares | Defined | 2025-11-13 | |
| 2024-12-31 | $863,791 | 2,145 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,670,954 | 5,743 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,885,773 | 21,091 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $7,454,790 | 17,834 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,540,078 | 18,531 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,434,781 | 24,256 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,383,903 | 23,824 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $11,695,398 | 37,120 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $45,465,811 | 157,441 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $35,291,741 | 121,889 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,234,249 | 18,575 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $6,382,543 | 24,457 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,993,309 | 9,077 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $61,300,931 | 337,951 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $50,322,210 | 249,577 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $10,782,320 | 50,176 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $10,818,699 | 45,776 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,851,668 | 21,504 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $5,073,457 | 17,476 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,182,849 | 4,971 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||